30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Inari Medical Inc (NARI)

Track

Stock chart
Ticker: NARI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hoffman William
2 sales — total 12,093,175 USD
Planned sale 6 Jan 2025
Value US$3,958,568.16 | Price 320.65 | Shares 85,299
Planned sale 6 Jan 2025
Value US$2,376,281.45 | Price 414.53 | Shares 89,812
Proposed sale 6 Jan 2025
Value US$3,686,754.93 | Price 42.25 | Shares 59,031
Planned sale 20 Dec 2024
Value US$33,390.00 | Price 55.65 | Shares 600
Planned sale 20 Dec 2024
Value US$132,480.00 | Price 55.20 | Shares 2,400
Planned sale 16 Dec 2024
Value US$7,509.48 | Price 56.89 | Shares 132
Planned sale 16 Dec 2024
Value US$421,960.17 | Price 56.51 | Shares 7,467
Planned sale 16 Dec 2024
Value US$569,336.27 | Price 55.27 | Shares 10,301
Planned sale 16 Dec 2024
Value US$114,282.00 | Price 54.42 | Shares 2,100
Planned sale 16 Dec 2024
Value US$133,356.54 | Price 56.82 | Shares 2,347
Planned sale 16 Dec 2024
Value US$765,462.00 | Price 56.45 | Shares 13,560
Planned sale 16 Dec 2024
Value US$1,155,245.91 | Price 55.23 | Shares 20,917
Planned sale 16 Dec 2024
Value US$172,552.08 | Price 54.33 | Shares 3,176
Proposed sale 12 Dec 2024
Value US$174,630.00 | Price 58.21 | Shares 3,000
Planned sale 10 Dec 2024
Value US$220,000.00 | Price 55.00 | Shares 4,000
Proposed sale 10 Dec 2024
Value US$213,560.00 | Price 53.39 | Shares 4,000
Planned sale 20 Nov 2024
Value US$152,490.00 | Price 50.83 | Shares 3,000
Planned sale 18 Nov 2024
Value US$498,810.00 | Price 51.16 | Shares 9,750
Planned sale 18 Nov 2024
Value US$519,060.00 | Price 50.64 | Shares 10,250
Planned sale 18 Nov 2024
Value US$167,585.76 | Price 52.11 | Shares 3,216
Planned sale 18 Nov 2024
Value US$1,733,794.88 | Price 51.32 | Shares 33,784
Planned sale 18 Nov 2024
Value US$150,270.00 | Price 50.09 | Shares 3,000
Proposed sale 18 Nov 2024
Value US$6,067,200.00 | Price 50.56 | Shares 120,000
Planned sale 29 Oct 2024
Value US$150,000.00 | Price 50.00 | Shares 3,000
Planned sale 29 Oct 2024
Value US$1,000,000.00 | Price 50.00 | Shares 20,000
Planned sale 29 Oct 2024
Value US$1,002,000.00 | Price 50.10 | Shares 20,000
Proposed sale 29 Oct 2024
Value US$383,040.00 | Price 42.56 | Shares 9,000
Planned sale 16 Oct 2024
Value US$555,771.72 | Price 45.57 | Shares 12,196
Planned sale 16 Oct 2024
Value US$1,245,063.12 | Price 44.78 | Shares 27,804
Planned sale 16 Sep 2024
Value US$341,750.22 | Price 46.27 | Shares 7,386
Planned sale 16 Sep 2024
Value US$1,491,438.22 | Price 45.73 | Shares 32,614
Planned sale 12 Sep 2024
Value US$23,170.00 | Price 46.34 | Shares 500
Planned sale 12 Sep 2024
Value US$40,807.80 | Price 45.80 | Shares 891
Planned sale 12 Sep 2024
Value US$71,407.42 | Price 44.38 | Shares 1,609
Proposed sale 12 Sep 2024
Value US$540,840.00 | Price 45.07 | Shares 12,000
Planned sale 20 Aug 2024
Value US$150,000.00 | Price 50.00 | Shares 3,000
Planned sale 19 Aug 2024
Value US$1,006,000.00 | Price 50.30 | Shares 20,000
Proposed sale 19 Aug 2024
Value US$6,882,400.00 | Price 49.16 | Shares 140,000
Planned sale 16 Aug 2024
Value US$759,528.99 | Price 49.17 | Shares 15,447
Planned sale 16 Aug 2024
Value US$1,196,222.16 | Price 48.72 | Shares 24,553
Planned sale 12 Aug 2024
Value US$20,686.56 | Price 48.56 | Shares 426
Planned sale 12 Aug 2024
Value US$219,277.56 | Price 47.94 | Shares 4,574
Planned sale 22 Jul 2024
Value US$165,690.00 | Price 55.23 | Shares 3,000
Planned sale 16 Jul 2024
Value US$188,645.31 | Price 58.17 | Shares 3,243
Planned sale 16 Jul 2024
Value US$260,144.04 | Price 57.72 | Shares 4,507
Planned sale 16 Jul 2024
Value US$271,230.94 | Price 56.53 | Shares 4,798
Planned sale 16 Jul 2024
Value US$313,855.56 | Price 55.53 | Shares 5,652
Planned sale 16 Jul 2024
Value US$98,460.00 | Price 54.70 | Shares 1,800
Planned sale 16 Jul 2024
Value US$152,149.00 | Price 58.25 | Shares 2,612
Planned sale 16 Jul 2024
Value US$924,894.60 | Price 57.90 | Shares 15,974
Planned sale 16 Jul 2024
Value US$472,499.58 | Price 56.58 | Shares 8,351
Planned sale 16 Jul 2024
Value US$536,364.27 | Price 55.53 | Shares 9,659
Planned sale 16 Jul 2024
Value US$186,403.04 | Price 54.76 | Shares 3,404
Planned sale 16 Jul 2024
Value US$191,956.80 | Price 55.16 | Shares 3,480
Proposed sale 16 Jul 2024
Value US$5,480,000.00 | Price 54.80 | Shares 100,000
Planned sale 15 Jul 2024
Value US$181,830.00 | Price 55.10 | Shares 3,300
Planned sale 15 Jul 2024
Value US$181,764.00 | Price 55.08 | Shares 3,300
Planned sale 15 Jul 2024
Value US$546,492.80 | Price 55.09 | Shares 9,920
Proposed sale 15 Jul 2024
Value US$1,305,840.00 | Price 54.41 | Shares 24,000
Planned sale 12 Jul 2024
Value US$106,719.15 | Price 54.31 | Shares 1,965
Planned sale 12 Jul 2024
Value US$163,040.20 | Price 53.72 | Shares 3,035
Planned sale 1 Jul 2024
Value US$1,003,000.00 | Price 50.15 | Shares 20,000
Planned sale 1 Jul 2024
Value US$150,240.00 | Price 50.08 | Shares 3,000
Proposed sale 1 Jul 2024
Value US$433,350.00 | Price 48.15 | Shares 9,000
Planned sale 21 Jun 2024
Value US$11,957.40 | Price 45.99 | Shares 260
Planned sale 17 Jun 2024
Value US$4,585.00 | Price 45.85 | Shares 100
Planned sale 17 Jun 2024
Value US$95,710.00 | Price 45.04 | Shares 2,125
Planned sale 17 Jun 2024
Value US$272,688.00 | Price 44.16 | Shares 6,175
Planned sale 17 Jun 2024
Value US$1,368,596.00 | Price 43.31 | Shares 31,600
Planned sale 12 Jun 2024
Value US$120,196.08 | Price 48.04 | Shares 2,502
Planned sale 12 Jun 2024
Value US$117,780.70 | Price 47.15 | Shares 2,498
Proposed sale 12 Jun 2024
Value US$713,550.00 | Price 47.57 | Shares 15,000
Planned sale 28 May 2024
Value US$150,000.00 | Price 50.00 | Shares 3,000
Planned sale 28 May 2024
Value US$3,007,800.00 | Price 50.13 | Shares 60,000
Proposed sale 28 May 2024
Value US$149,850.00 | Price 49.95 | Shares 3,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-08 2025-01-06 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
85,299 -26.1%
320.65
US$3,958,568 		85,299 -26.1% 320.65 US$3,958,568
2025-01-08 2025-01-06 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
89,812 +38.9%
414.53
US$2,376,281 		89,812 +38.9% 414.53 US$2,376,281
2025-01-06 2025-01-06 PrS Proposed sale
2.9
WILLIAM HOFFMAN

Director

Non-Executive Director
59,031
42.25
US$3,686,755 		59,031 42.25 US$3,686,755
2024-12-20 2024-12-20 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
600 -0.1%
55.65
US$33,390 		600 -0.1% 55.65 US$33,390
2024-12-20 2024-12-20 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
2,400 -0.5%
55.20
US$132,480 		2,400 -0.5% 55.20 US$132,480
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
132 -0.0%
56.89
US$7,509 		132 -0.0% 56.89 US$7,509
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
7,467 -1.7%
56.51
US$421,960 		7,467 -1.7% 56.51 US$421,960
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
10,301 -2.2%
55.27
US$569,336 		10,301 -2.2% 55.27 US$569,336
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
2,100 -0.5%
54.42
US$114,282 		2,100 -0.5% 54.42 US$114,282
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
2,347 -0.5%
56.82
US$133,357 		2,347 -0.5% 56.82 US$133,357
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
13,560 -2.8%
56.45
US$765,462 		13,560 -2.8% 56.45 US$765,462
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
20,917 -4.2%
55.23
US$1,155,246 		20,917 -4.2% 55.23 US$1,155,246
2024-12-18 2024-12-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
3,176 -0.6%
54.33
US$172,552 		3,176 -0.6% 54.33 US$172,552
2024-12-12 2024-12-12 PrS Proposed sale
MITCH HILL

Officer

Officer
3,000
58.21
US$174,630 		3,000 58.21 US$174,630
2024-12-12 2024-12-10 PlS Planned sale
3.1
Tu Thomas

Chief Medical Officer

Officer
4,000 -1.3%
55.00
US$220,000 		4,000 -1.3% 55.00 US$220,000
2024-12-10 2024-12-10 PrS Proposed sale
3.1
THOMAS TU

Officer

Officer
4,000
53.39
US$213,560 		4,000 53.39 US$213,560
2024-11-22 2024-11-20 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
3,000 -0.7%
50.83
US$152,490 		3,000 -0.7% 50.83 US$152,490
2024-11-20 2024-11-18 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
9,750 -1.9%
51.16
US$498,810 		9,750 -1.9% 51.16 US$498,810
2024-11-20 2024-11-18 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
10,250 -2.0%
50.64
US$519,060 		10,250 -2.0% 50.64 US$519,060
2024-11-20 2024-11-18 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
3,216 -0.6%
52.11
US$167,586 		3,216 -0.6% 52.11 US$167,586
2024-11-20 2024-11-18 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
33,784 -6.1%
51.32
US$1,733,795 		33,784 -6.1% 51.32 US$1,733,795
2024-11-20 2024-11-18 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
3,000 -0.5%
50.09
US$150,270 		3,000 -0.5% 50.09 US$150,270
2024-11-18 2024-11-18 PrS Proposed sale
2.9
WILLIAM HOFFMAN

Director

Non-Executive Director
120,000
50.56
US$6,067,200 		120,000 50.56 US$6,067,200
2024-10-31 2024-10-29 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
3,000 -0.7%
50.00
US$150,000 		3,000 -0.7% 50.00 US$150,000
2024-10-31 2024-10-29 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
20,000 -3.4%
50.00
US$1,000,000 		20,000 -3.4% 50.00 US$1,000,000
2024-10-31 2024-10-29 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
20,000 -3.3%
50.10
US$1,002,000 		20,000 -3.3% 50.10 US$1,002,000
2024-10-29 2024-10-29 PrS Proposed sale
3.1
ANDREW J HYKES

Director; Officer

Executive Director
9,000
42.56
US$383,040 		9,000 42.56 US$383,040
2024-10-18 2024-10-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
12,196 -2.0%
45.57
US$555,772 		12,196 -2.0% 45.57 US$555,772
2024-10-18 2024-10-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
27,804 -4.3%
44.78
US$1,245,063 		27,804 -4.3% 44.78 US$1,245,063
2024-09-18 2024-09-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
7,386 -1.1%
46.27
US$341,750 		7,386 -1.1% 46.27 US$341,750
2024-09-18 2024-09-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
32,614 -4.8%
45.73
US$1,491,438 		32,614 -4.8% 45.73 US$1,491,438
2024-09-13 2024-09-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
500 -0.3%
46.34
US$23,170 		500 -0.3% 46.34 US$23,170
2024-09-13 2024-09-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
891 -0.5%
45.80
US$40,808 		891 -0.5% 45.80 US$40,808
2024-09-13 2024-09-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
1,609 -0.9%
44.38
US$71,407 		1,609 -0.9% 44.38 US$71,407
2024-09-12 2024-09-12 PrS Proposed sale
MITCH HILL

Officer

Officer
12,000
45.07
US$540,840 		12,000 45.07 US$540,840
2024-08-22 2024-08-20 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
3,000 -0.7%
50.00
US$150,000 		3,000 -0.7% 50.00 US$150,000
2024-08-20 2024-08-19 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
20,000 -2.8%
50.30
US$1,006,000 		20,000 -2.8% 50.30 US$1,006,000
2024-08-19 2024-08-19 PrS Proposed sale
2.9
WILLIAM HOFFMAN

Director

Non-Executive Director
140,000
49.16
US$6,882,400 		140,000 49.16 US$6,882,400
2024-08-20 2024-08-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
15,447 -2.1%
49.17
US$759,529 		15,447 -2.1% 49.17 US$759,529
2024-08-20 2024-08-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
24,553 -3.3%
48.72
US$1,196,222 		24,553 -3.3% 48.72 US$1,196,222
2024-08-14 2024-08-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
426 -0.2%
48.56
US$20,687 		426 -0.2% 48.56 US$20,687
2024-08-14 2024-08-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
4,574 -2.5%
47.94
US$219,278 		4,574 -2.5% 47.94 US$219,278
2024-07-24 2024-07-22 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
3,000 -0.7%
55.23
US$165,690 		3,000 -0.7% 55.23 US$165,690
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
3,243 -0.4%
58.17
US$188,645 		3,243 -0.4% 58.17 US$188,645
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
4,507 -0.6%
57.72
US$260,144 		4,507 -0.6% 57.72 US$260,144
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
4,798 -0.6%
56.53
US$271,231 		4,798 -0.6% 56.53 US$271,231
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
5,652 -0.7%
55.53
US$313,856 		5,652 -0.7% 55.53 US$313,856
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
1,800 -0.2%
54.70
US$98,460 		1,800 -0.2% 54.70 US$98,460
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
2,612 -0.3%
58.25
US$152,149 		2,612 -0.3% 58.25 US$152,149
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
15,974 -2.0%
57.90
US$924,895 		15,974 -2.0% 57.90 US$924,895
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
8,351 -1.1%
56.58
US$472,500 		8,351 -1.1% 56.58 US$472,500
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
9,659 -1.2%
55.53
US$536,364 		9,659 -1.2% 55.53 US$536,364
2024-07-18 2024-07-16 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
3,404 -0.4%
54.76
US$186,403 		3,404 -0.4% 54.76 US$186,403
2024-07-18 2024-07-16 PlS Planned sale
3.1
Tu Thomas

Chief Medical Officer

Officer
3,480 -1.1%
55.16
US$191,957 		3,480 -1.1% 55.16 US$191,957
2024-07-16 2024-07-16 PrS Proposed sale
2.9
WILLIAM HOFFMAN

Director

Non-Executive Director
100,000
54.80
US$5,480,000 		100,000 54.80 US$5,480,000
2024-07-16 2024-07-15 PlS Planned sale
3.1
Tu Thomas

Chief Medical Officer

Officer
3,300 -1.0%
55.10
US$181,830 		3,300 -1.0% 55.10 US$181,830
2024-07-16 2024-07-15 PlS Planned sale
3.1
Tu Thomas

Chief Medical Officer

Officer
3,300 -1.0%
55.08
US$181,764 		3,300 -1.0% 55.08 US$181,764
2024-07-16 2024-07-15 PlS Planned sale
3.1
Tu Thomas

Chief Medical Officer

Officer
9,920 -3.0%
55.09
US$546,493 		9,920 -3.0% 55.09 US$546,493
2024-07-15 2024-07-15 PrS Proposed sale
3.1
THOMAS TU

Officer

Officer
24,000
54.41
US$1,305,840 		24,000 54.41 US$1,305,840
2024-07-16 2024-07-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
1,965 -1.1%
54.31
US$106,719 		1,965 -1.1% 54.31 US$106,719
2024-07-16 2024-07-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
3,035 -1.6%
53.72
US$163,040 		3,035 -1.6% 53.72 US$163,040
2024-07-03 2024-07-01 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
20,000 -2.4%
50.15
US$1,003,000 		20,000 -2.4% 50.15 US$1,003,000
2024-07-03 2024-07-01 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
3,000 -0.6%
50.08
US$150,240 		3,000 -0.6% 50.08 US$150,240
2024-07-01 2024-07-01 PrS Proposed sale
3.1
ANDREW J HYKES

Director; Officer

Executive Director
9,000
48.15
US$433,350 		9,000 48.15 US$433,350
2024-06-24 2024-06-21 PlS Planned sale
0.7
Chambers Rebecca
Non-Executive Director
260 -2.6%
45.99
US$11,957 		260 -2.6% 45.99 US$11,957
2024-06-20 2024-06-17 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
100 -0.0%
45.85
US$4,585 		100 -0.0% 45.85 US$4,585
2024-06-20 2024-06-17 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
2,125 -0.3%
45.04
US$95,710 		2,125 -0.3% 45.04 US$95,710
2024-06-20 2024-06-17 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
6,175 -0.7%
44.16
US$272,688 		6,175 -0.7% 44.16 US$272,688
2024-06-20 2024-06-17 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
31,600 -3.7%
43.31
US$1,368,596 		31,600 -3.7% 43.31 US$1,368,596
2024-06-14 2024-06-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
2,502 -1.4%
48.04
US$120,196 		2,502 -1.4% 48.04 US$120,196
2024-06-14 2024-06-12 PlS Planned sale
Hill, Mitch C.

Chief Financial Officer

Officer
2,498 -1.3%
47.15
US$117,781 		2,498 -1.3% 47.15 US$117,781
2024-06-12 2024-06-12 PrS Proposed sale
MITCH HILL

Officer

Officer
15,000
47.57
US$713,550 		15,000 47.57 US$713,550
2024-05-30 2024-05-28 PlS Planned sale
3.1
Hykes Andrew

President and CEO

Executive Director
3,000 -0.6%
50.00
US$150,000 		3,000 -0.6% 50.00 US$150,000
2024-05-30 2024-05-28 PlS Planned sale
2.9
Hoffman William
Non-Executive Director
60,000 -6.5%
50.13
US$3,007,800 		60,000 -6.5% 50.13 US$3,007,800
2024-05-28 2024-05-28 PrS Proposed sale
3.1
ANDREW J HYKES

Director; Officer

Executive Director
3,000
49.95
US$149,850 		3,000 49.95 US$149,850
Explore more

More insider trading research around Inari Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America